Cytos Investigator Sites

Oklahoma City, Oklahoma

0 studies enrolling now · 1 studies all time

What they study most

Moderate to Severe Allergic Asthma

Studies at this site

• CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma — Stopped early